Riskpilot← Back to searchSign inGet full accessOSTEOPRO AS
ASActiveOrg 914158109Forskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 20140 employees
Revenue 2020
NOK 204K
-79% vs 2019
EBITDA margin
-3.5%
-101% vs 2019
Equity ratio
66.5%
Financial strength
Net profit 2020
NOK -218K
-176% vs 2019
| Revenue | NOK 204K | -79% |
| EBITDA | NOK -7K | -101% |
| Net profit | NOK -218K | -176% |
| Total assets | NOK 938K | -34% |
| Equity | NOK 624K | -26% |
| Employees | 0 | — |
Legal name
OSTEOPRO AS
Org number
914158109
Legal form
Aksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
29. oktober 2014
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Klinisk virksomhet og medisinsk forskning, samt herunder deltakelse i andre selskaper og foretagender med lignende virksomhet, samt kjøp og salg av fast eiendom.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 884 | 446 | 756 | 981 | 204 |
| Staff expenses | −2 | −19 | −19 | −18 | −20 |
| EBITDA | 798 | 363 | 468 | 647 | −7 |
| Depreciation & amort. | −20 | −213 | −224 | −203 | −203 |
| EBIT | 779 | 150 | 244 | 444 | −210 |
| Net financials | −0 | −0 | 4 | −28 | −8 |
| Profit before tax | 778 | 150 | 248 | 416 | −218 |
| Tax | 197 | 33 | 57 | 128 | −0 |
| Net profit | 581 | 116 | 191 | 287 | −218 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1 422 | 1 366 | 1 369 | 1 427 | 938 |
| Equity | 697 | 920 | 604 | 842 | 624 |
| Long-term debt | 74 | 379 | 525 | 417 | 302 |
| Short-term debt | 651 | 67 | 239 | 169 | 12 |
| Total debt | 725 | 446 | 765 | 585 | 314 |
EBITDA margin
-3.5%
This company
15.8%
Market median
-122% vs market
20162020
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20162020
Return on equity
-34.9%
This company
18.4%
Market median
-290% vs market
20162020
Net profit margin
-106.8%
This company
8.1%
Market median
-1419% vs market
20162020
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20162020
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CB Deputy Member | Deputy Member | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OSTEOPRO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Catherine Barbara Fink Eriksen | Deputy Member | 0 companies |
| Erik Fink Eriksen | Chairman | 0 companies |